In India, "New Drugs" are defined in The Drugs & Cosmetics Rules, 1945 as :
Rule 122E. Definition of new drug.-
For the purpose of this Part, new drug shall mean and include-
(a) A drug, as defined in the Act including bulk drug substance or phytopharmaceutical drug which has not been used in the country to any significant extent under the conditions prescribed, recommended or suggested in the labelling thereof and has not been recognized as effective and safe by the licensing authority mentioned under rule 21 for the proposed claims:
Provided that the limited use, if any, has been with the permission of the licensing authority.
(b) A drug already approved by the Licensing Authority mentioned in Rule 21 for certain claims, which is now proposed to be marketed with modified or new claims, namely, indications, dosage, dosage form (including sustained release dosage form) and route of administration.
(c) A fixed dose combination of two or more drugs, individually approved earlier for certain claims, which are now proposed to be combined for the first time in a fixed ratio, or if the ratio of ingredients in an already marketed combination is proposed to be changed, with certain claims, viz. indications, dosage, dosage form (including sustained release dosage form) and route of administration. (See items (b) and (c) of Appendix VI to Schedule Y.)
Explanation.- For the purpose of this rule−
(i) all vaccines and Recombinant DNA (r-DNA) derived drugs shall be new drugs unless certified otherwise by the Licensing Authority under Rule 21;
(ii) a new drug shall continue to be considered as new drug for a period of four years from the date of its first approval.
How New Drugs are defined in India?
- QualisBioMed
- Site Admin
- Posts: 9
- Joined: Sat Aug 07, 2021 4:03 pm
- Contact:
Jump to
- General
- ↳ Welcome
- ↳ Announcements
- Acts & Rules
- ↳ Acts
- ↳ Drugs & Cosmetics Act, 1940
- ↳ Narcotic Drugs & Psychotropic Substances Act, 1985
- ↳ The Drugs & Magic Remedies (Objectionable Advertisement) Act, 1954
- ↳ THE CODE OF CRIMINAL PROCEDURE, 1973 ACT NO. 2 OF 1974
- ↳ Rules
- ↳ Drugs & Cosmetics Rules, 1945
- ↳ Medical Devices Rules, 2017
- ↳ New Drugs & Clinical Trials Rules, 2019
- ↳ Cosmetics Rules, 2020
- ↳ Narcotic Drugs & Psychotropic Substances Rules, 1985
- ↳ The Drugs & Magic Remedies (Objectionable Advertisement) Act, 1955
- ↳ Drugs (Prices Control) Order, 1995
- ↳ Gazette Notifications
- Pharmaceuticals
- ↳ Drugs
- ↳ Investigational New Drugs (IND) and New Drugs
- ↳ Subsequent New Drugs (SND)
- ↳ Fixed Dose Combinations (FDC)
- ↳ Biological Products
- ↳ Vaccines
- ↳ Phytopharmaceuticals
- ↳ Dosage Form
- ↳ Tablet
- ↳ Capsule
- ↳ Injection
- ↳ Pre-clinical Studies
- ↳ Clinical Studies
- ↳ Drugs Discovery
- ↳ Pharmaceutical Technology
- ↳ Quality Control
- ↳ Quality Assurance
- ↳ Quality Management System (QMS)
- ↳ Validation
- ↳ Clinical Trials
- ↳ Audits
- ↳ cGMP
- ↳ Water System
- ↳ Aseptic Processing
- ↳ SOPs
- ↳ GLP
- ↳ Stability Studies
- ↳ Instrument Calibration
- ↳ Production Facility
- ↳ Regulatory Approvals
- In-Vitro Diagnostics (IVD)
- ↳ In-Vitro Diagnostics
- ↳ In-Vitro Diagnostics (IVD) Classifications
- ↳ Quality Management System (QMS)
- ↳ Clinical Performance Study
- ↳ Quality Control
- ↳ Quality Assurance
- ↳ Engineering Design
- ↳ Software Validation
- ↳ Regulatory Approvals
- Medical Devices
- ↳ Medical Devices
- ↳ Medical Devices Classifications
- ↳ Quality Management System (QMS)
- ↳ Clinical Evaluation Reports
- ↳ Quality Control
- ↳ Quality Assurance
- ↳ Engineering Design
- ↳ Software Validation
- ↳ Regulatory Approval
- Cosmetics
- ↳ Cosmetics
- ↳ Regulatory Approval
- ↳ Manufacturing of Cosmetics
- ↳ Export / Import of Cosmetics
- ↳ Pre-Clinical Studies
- ↳ Clinical Studies
- Regulatory Updates from various National Regulatory Authorities
- ↳ Updates in Acts & Rules
- ↳ Draft Notifications
- National Regulatory Authorities (NRA)
- ↳ List of National Regulatory Authorities and their Role Healthcare
- ↳ List of Non-Statutory Agencies and their Role in HealthCare
- Intellectual Property Rights (IPR)
- ↳ Intellectual Property Rights
- ↳ Intellectual Property Rights classification
- ↳ Patent
- ↳ Miscellaneous
- Medical Products Guidelines from various Agencies
- ↳ World Health Organisation (WHO)
- ↳ International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH)
- Pharmacopoeia
- ↳ USP (United States Pharmacopeia )
- ↳ IP (Indian Pharmacopoeia )
- ↳ JP (Japanese Pharmacopoeia )
- ↳ EP (European Pharmacopoeia )
- ↳ Comparative topics across various Pharmacopoeia
- World Trade Organization (WTO)
- ↳ World Trade Organization and its role in the world economy
- ↳ Various treaties under WTO
- Artificial Intelligence and way ahead
- ↳ Artificial Intelligence
- ↳ Artificial Intelligence in Medical Products ( diagnostics and treatments)
- ↳ Challenges in Artificial Intelligence
- ↳ Products specific Artificial Intelligence (Case Studies)